Cell death can proceed through at least two distinct pathways. Apoptosis is an energy-dependent process characterized morphologically by cell shrinkage, whereas oncosis is a form of cell death induced by energy depletion and initially characterized by cell swelling. We demonstrate in HeLa cells but not in normal diploid fibroblasts that modest increases in the expression level of uncoupling protein 2 (UCP-2) leads to a rapid and dramatic fall in mitochondrial membrane potential and to a reduction of mitochondrial NADH and intracellular ATP. In HeLa cells, increased UCP-2 expression leads to a form of cell death that is not inhibited by the anti-apoptotic gene product Bcl-2 and that morphologically resembles cellular oncosis. We further describe the creation of a dominant interfering mutant of UCP-2 whose expression increases resting mitochondrial membrane potential and selectively increases the resistance to cell death following oncotic but not apoptotic stimuli. These results suggest that distinct genetic programs may regulate the cellular response to either apoptotic or oncotic stimuli.
Mitochondria appear to connect multiple cellular stress signals with cell death machinery. In apoptosis, the signaling proteins such as Bax and the orphan nuclear receptor TR3 localize to the mitochondria and regulate its function, culminating in lowered mitochondrial membrane potential, increased membrane permeability, and the release of a mixture of death effectors including the procaspases cytochrome c and SMAC/DIABLO (1) (2) (3) . In oncosis, cellular energy depletion following metabolic insults such as severe ischemia produces dramatic reductions in mitochondrial respiration and ATP synthesis, resulting in a loss of ionic homeostasis and cellular swelling (4) . Because the mitochondrial generation of ATP requires the presence of an electrochemical gradient, a reduction in mitochondrial membrane potential (⌿M) may precede the morphologic changes seen in apoptotic and oncotic cell death (5) .
In contrast to the relatively detailed knowledge accrued concerning the mitochondrial control of apoptosis, surprisingly little is known regarding the controlling mechanisms in oncotic cell death. Oncosis has long been confused with necrosis, but similar to apoptosis, it refers to a process leading to cell death, whereas necrosis refers to those processes of cellular degradation that follow cell death (4) . Oncosis has typically been regarded as passive, occurring after only severe tissue injury brought about by ischemia or heat (6) , but more recently oncotic cells have been observed coincident with apoptosis in atherosclerotic lesions of vessel endothelium (7) , pancreatic dysfunction (8) , and infarcted myocardial tissue (9) . Recent evidence suggests that oncosis in mammalian cells may be regulated in part by cell surface receptors (10) , and in plants, oncosis may function like apoptosis in the maintenance of tissue homeostasis (11) . Interestingly, a recent report indicates that oncotic cells, similar to their apoptotic counterparts, expose phosphatidylserine on the plasma membrane surface, an event required for the engulfment of dying cells by phagocytes and necessary for the prevention of necrotic tissue damage and inflammation (12) .
In animals, uncoupling protein 1 (UCP-1) 1 is highly expressed in the inner mitochondrial membrane of brown adipocytes and regulates mitochondrial membrane potential by allowing the re-entry of protons that have been pumped out of the mitochondrial matrix during aerobic respiration (13, 14) . This proton leak reduces net cellular ATP production in exchange for the generation of heat, a property that is essential for the function of UCP-1 in mediating cold-induced thermogenesis. The biochemical analysis of UCP-1 has revealed that the rate of proton transport is highly dependent on fatty acids, purine nucleotides, and intracellular pH, although the exact mechanisms of proton translocation remain controversial (15) . Recently, a number of UCP-1 homologues have been described. The expression of UCP-3 is restricted predominantly to skeletal muscle and brown adipose tissue mitochondria, whereas UCP-2 has a much wider tissue distribution (16) . Given their high degree of structural similarity, it is widely believed that the recently described UCP family members may also regulate proton leak and hence ⌿M in tissues besides brown fat. Although UCP-2 has recently been extensively examined for its potential role in diabetes, its overall metabolism, and as a mediator of obesity (17, 18) , controversy exists as to whether the protein truly acts to uncouple mitochondria and whether or not UCP-2 regulates mitochondrial membrane potential and cellular energetics (19) . Here, we sought to further understand the role of UCP-2 in mitochondrial function and its role in mammalian cell death pathways.
EXPERIMENTAL PROCEDURES
Plasmid Construction and Transfections-For transient transfections, full-length human UCP-2 cDNA (a generous gift of C. H. Warden) was subcloned into the expression vector pCDNA3.1 and transfected * The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
ʈ To whom correspondence should be addressed: Cardiovascular Branch, 10 Center Dr., Bldg. 10/6N-240, Bethesda, MD 20892-1622. Tel.: 301-402-4081; Fax: 301-402-9311; E-mail: finkelt@nih.gov. using LipofectAMINE (Invitrogen) into HeLa cells along with a nuclear localizing green fluorescent protein construct pCMV-GFPnuc (Invitrogen). The expression plasmid for adenine nucleotide translocator (ANT-2) was obtained by PCR amplification of a human heart library, and its sequence was confirmed by direct nucleotide sequencing. Sitedirected mutants of UCP-2 were created by substitution at position 28 (Asp-Asn), position 185 (Arg-Gln), or position 212 (Asp-Asn). The mutations were confirmed by sequencing, and expression was confirmed using an in-frame epitope expression tag.
Retroviral Overexpression of UCP-2 and Determination of Fibroblast Growth Rate-A virus encoding full-length human UCP-2 and a G418 selection marker was constructed using the retroviral vector pLNCX (CLONTECH) according to the manufacturer's instructions. Retroviral stocks were prepared following transfection in 10-cm 2 dishes (15 g/5 ϫ 10 5 cells) of the producer cell line PT-67 per manufacturer's recommendations by the (CLONTECH). Control human diploid fibroblasts at an approximate population doubling time of 20 -25 were obtained following infection with a retrovirus encoding for only neomycin resistance. Following selection in G418 (500 g/ml for 7 days), the control and UCP-2-infected cells were replated at similar densities. For growth rate, cells were seeded at 4 ϫ 10 4 /well in 6-well plates, and population doubling was determined as follows: [log (number of cells harvested/number of cells seeded)]/log2.
Western Blotting and Immunohistochemical Analysis-One day after transfection, whole cell protein lysates were prepared from mock-transfected and UCP-2-transfected HeLa cells (5 mg of protein lysate/lane) and probed with rabbit anti-UCP-2 (Alpha Diagnostics, San Antonio, TX) or mouse anti-tubulin (Santa Cruz Biotechnology, Santa Cruz, CA) antibodies. Similarly, the levels of Bcl-2 expression were assessed using an anti-Bcl-2 (Santa Cruz Biotechnology) antibody. Proteins were visualized by enhanced chemiluminescence. For cytochrome oxidase 2 (COX-2) immunofluorescence, cells were co-transfected with empty vector or UCP-2 along with nuclear localizing green fluorescent protein (GFPnuc) and fixed 24 h after transfection in 3% paraformaldehyde. Indirect immunofluorescence was performed using an anti-COX-2 mouse monoclonal antibody (1.0 mg/ml, Molecular Probes) followed by an anti-mouse Texas Red-conjugated secondary antibody (Molecular Probes). Transfected cells as evidenced by GFP fluorescence were subsequently visualized with a Zeiss laser scanning confocal microscope (LSM-510).
Assessment of Mitochondrial Membrane Potential-HeLa cells were grown on 2-well coverglass chamber slides. Twenty four hours after transfection, mitochondrial potentiometric dyes (tetramethylrhodamine methyl ester (TMRM) and Mitotracker Red (CMXRos), Molecular Probes) were diluted separately in medium (final concentration of 25 nM) and then added to wells in the dark for 15 min at 37°C. The cells were subsequently washed twice with Hanks' solution (pH 7.4) and immediately imaged on an inverted Zeiss Axiovert LSM-510 laser scanning confocal microscope. For TMRM experiments after the initial incubation, cells were washed and maintained in Hanks' solution containing 2.5 nM TMRM. For all of the experiments, either pCDNA-UCP-2 or the corresponding empty vector DNA was transfected at a 4:1 molar ratio with pCMV-GFPnuc. For CMXRos, relative fluorescence in each transfection group was determined by assessing the ratio in random fields of the level of mitochondrial CMXRos fluorescence in GFP-positive cells versus neighboring cells that were GFP-negative. Relative TMRM fluorescence and millivolt membrane potentials in each transfection group were also determined ratiometrically by comparing mitochondrial to nuclear fluorescence in GFP-positive cells and subtracting extracellular background fluorescence using an IDL-based (Boulder, CO) program. Quantitative results are from four separate experiments for CMXRos and from two separate experiments using TMRM, measuring ϳ15-25 GFP-positive cells/experiment. The membrane potentials were similarly determined in non-transfected cells following treatments with chemical uncouplers dinitrophenol (DNP, Sigma), carbonyl cyanide m-chlorophenylhydrazone (CCCP, Sigma), and oligomycin (Sigma). To determine whether transfected genes altered mitochondrial mass, cells were analyzed by a fluorescence-activated cell sorter (FACS) using the non-potentiometric dye Mitotracker Green (50 nM, Molecular Probes) under the same conditions employed for CMXRos. To assess the ability of the UCP-2 site-directed mutants to alter mitochondrial membrane potential, cells were transiently transfected with a GFP expression plasmid and either a UCP-2 mutant or empty vector. Two days after transfection, CMXRos uptake in GFP-positive cells was assessed by FACS.
Quantitation of Mitochondrial NADH Autofluorescence and ATP Measurements-Mitochondrial NADH autofluorescence was monitored by confocal microscopy as described previously (20) . The images were processed using LSM-510 image analysis software. Images shown are representative field images of 8 -10 independent experiments performed in duplicate. For ATP determinations, cells were transfected with UCP-2/GFP-actin (CLONTECH) or pCDNA3.1/GFP-actin, and 48 h later, cells were sorted for green fluorescence. In duplicate experiments, approximately one million GFP-positive cells in each group were divided into four aliquots, and a luciferase-based ATP measurement kit (Molecular Probes) was used according to the manufacturer's instructions with values normalized for total protein. ATP levels were similarly determined in cells treated with dinitrophenol.
Cell Viability Measurements-To assess the effects of UCP-2 on cell viability, G418 selection was performed on cells transfected with a neomycin-resistant plasmid and a UCP-2 expression vector or the corresponding empty vector in a 1:10 ratio. Two days following transfection, cells were switched to medium containing 500 g/ml G418 sulfate. Ten days after initiation of antibiotic selection, cells were fixed, and viable colonies were stained with methyl violet. For the assessment of viability following transient transfection, cells were co-transfected with GFP-actin along with either a UCP-2 expression vector or with the corresponding empty vector (1:4 ratio). Two days after transfection, cells were trypsinized and analyzed on a FACS. GFP-positive cells from the UCP-2-transfected or control-transfected population were collected and subsequently analyzed for viability by trypan blue exclusion (0.2%, 5 min). Using the same conditions, similar studies were performed on a stable HeLa cell line expressing Bcl-2 generated by transfection of an expression vector encoding Bcl-2 (a generous gift of S. Korsmeyer) followed by G418 selection. As a control, a clonal HeLa cell line expressing G418 resistance alone was generated in parallel. Viability data reflect one representative experiment of at least two similar experiments each performed in quadruplicate. For determination of the effects of the mutant UCP-2 D212N on cell survival, cells were transfected with either the UCP-2 mutant or empty vector, and after 24 h, cells were treated with tumor necrosis factor-␣/cycloheximide (10 and 1 mg/ml, 4 or 8 h), staurosporine (1.0 mM, 4 or 8 h), sodium azide (1.5 mM, 15 or 24 h), or hypoxia (15 and 24 h). Cells were made hypoxic using a humidified hypoxia chamber (Billups and Rothenberg, Del Mar, CA) and were flushed of ambient air for 20 min with 95% N 2 , 5% CO 2 prior to incubation at 37°C. After the various treatments, viable cells were determined by assessing the number of trypan blue-negative cells remaining. For morphological determinations, the control and UCP-2-transfected cells were sorted for GFP fluorescence using FACS, collected on ice and fixed in glutaraldehyde buffer, and subsequently processed for electron microscopy. Thin sections were analyzed with a JEOL 100 CX transmission electron microscope.
RESULTS
In an effort to more fully understand the function of UCP-2 in mammalian cells, we employed laser scanning confocal microscopy along with two different fluorescent indicators of mitochondrial membrane potential, CMXRos and TMRM. HeLa cells were assessed 24 h after co-transfection with expression plasmids encoding UCP-2 and a GFPnuc as a marker of transfection. Using the densitometric ratio of UCP-2 to tubulin expression and calculating the overall transfection efficiency as assessed by GFP positivity, we determined that in transfected cells the levels of UCP-2 increased ϳ3-fold (Fig. 1) . However, this relatively modest increase in UCP-2 protein levels was associated with a significant reduction in mitochondrial membrane potential. As evidenced in Fig. 2A in control HeLa cells transfected with empty vector and GFPnuc, the levels of CMXRos fluorescence were similar in transfected cells when compared with non-transfected neighboring cells. In contrast, cells expressing UCP-2 had a dramatic reduction in mitochondrial membrane potential as determined by CMXRos fluorescence (Fig. 2, B and C) . A quantitative assessment for mitochondrial membrane potential 24 h after transfection demonstrated that in contrast to control-transfected cells expressing GFPnuc alone, the expression of UCP-2 resulted in an approximate 80% reduction in CMXRos uptake (Fig. 2D) . To further confirm the specificity of the observed effects of UCP-2 on membrane potential, we also overexpressed the mitochondrial carrier protein, ANT-2. As observed in Fig. 2D , in contrast to UCP-2, ANT-2 expression did not alter CMXRos fluorescence. Because all of the fluorescent probes of mitochondrial membrane potential have limitations including sensitivity to plasma membrane potential, we extended our initial observations using TMRM, which at low concentrations is insensitive to plasma membrane potential (14) . Similar to what we observed with CMXRos, UCP-2 also significantly reduced TMRM fluorescence ratios (Fig. 2E) . Although individual mitochondria exhibited a significant range of membrane potentials, millivolt potentials in non-UCP-2-expressing cells were calculated to range from Ϫ99 to Ϫ120 mV. In marked contrast, millivolt potentials in UCP-2-transfected cells ranged from Ϫ35 to Ϫ116 mV. We further verified the membrane potential determinations in our system by assessing CMXRos uptake after treatment with either the chemical uncouplers DNP or CCCP or following exposure to the F 1 ATPase inhibitor oligomycin. As expected, each of these agents significantly reduced mitochondrial membrane potential (Fig. 2F) . Finally, to verify that reductions in dye uptake were not simply a function of reduced mitochondrial mass, we immunostained transfected cells with an antibody directed at the mitochondrial protein COX-2. As seen in Fig. 2, G and H Fig. 2I following transient transfection with UCP-2, a population of cells with lower membrane potential develops as evidenced by reduced CMXRos uptake. In contrast, the uptake of Mitotracker Green, a mitochondrial dye whose uptake is proportional to mitochondrial mass but not potential, was similar in control-and UCP-2-transfected cells (Fig. 2J) .
To begin to understand the effects of increased UCP-2 expression on cellular energetics, we next used microfluorometry to measure mitochondrial NADH levels. Compared with cells transfected with GFPnuc alone (Fig. 3, A and B) , HeLa cells expressing UCP-2 (Fig. 3, C and D) had reduced levels of NADH. A quantitative assessment demonstrated that UCP-2 resulted in an approximate 30% reduction in NADH levels (Fig.  3E) . Consistent with the effects on mitochondrial NADH, the direct measurement of cellular ATP levels 24 h after transfection revealed that total ATP stores fell ϳ40% in UCP-2-expressing HeLa cells (Fig. 3F) .
In an effort to pursue these observations, we next attempted to obtain stable cell lines that overexpressed UCP-2. Repeated attempts to obtain such stable cell lines in HeLa cells were unsuccessful. To evaluate these observations further, we compared the number of G418-resistant colonies in the presence or absence of UCP-2 transfection. As demonstrated in Fig. 4A , UCP-2 had a dramatic reduction in growth and/or survival of HeLa cells following neomycin selection. A similar decrease in cell survival was noted in cells transiently expressing UCP-2 (Fig. 4B) . Again, the expression of UCP-2 led to a significant reduction in cell viability with ϳ75% UCP-2-expressing cells becoming non-viable after 48 h following transfection. A microscopic analysis of UCP-2-transfected cells demonstrated that although some cells exhibited a morphological appearance consistent with apoptosis, a significantly larger number of cells appeared enlarged and swollen. Fig. 4C represents an example of UCP-2-transfected cells stained with toluidine blue with oncotic cells demonstrating reduced dye uptake. In control cells, the number of similarly enlarged lightly stained cells was significantly less (data not shown). The electron micrographs of the UCP-2-expressing cells demonstrated a mode of cell death consistent with oncosis. In particular, as demonstrated in Fig.  4D , there is evidence of cell and organelle swelling along with lysosomal accumulation. Similarly, as opposed to apoptosis, there is an absence of nuclear condensation. In addition, the expression of the anti-apoptotic gene product Bcl-2 had no effect on the loss of cell viability following transient UCP-2 expression (Fig. 4E) . These results are consistent with the observed effects on energy depletion seen in Fig. 3 and suggest that UCP-2 induces a form of cell death that morphologically resembles oncosis. To compare the differential effects of UCP-2-mediated uncoupling on transformed and normal cells, we overexpressed UCP-2 in human fibroblasts using a retroviral vector. As seen in Fig. 5A , retroviral overexpression resulted in an approximate 3-fold increase in UCP-2 protein expression compared with control-infected cells, a level similar to that observed in transfected HeLa cells. Interestingly, UCP-2 overexpression did not significantly alter the growth and viability of these fibroblast cells (Fig. 5B) , suggesting that fibroblast and HeLa cells have differential susceptibilities to uncoupling or that the regulation of overexpression of UCP-2 is different in each cell type. To begin to address these two possibilities, we compared the effects of chemical uncoupling on mitochondrial energetics in the two cell types using DNP. DNP (250 M) produced similar reductions in membrane potential in fibroblasts and HeLa cells following 6-and 24-h treatments (Fig. 5C ). In contrast, as seen in Fig.  5D , the fibroblasts displayed a much greater capacity to maintain intracellular NADH levels following DNP treatment. Consistent with NADH determinations, after a 24-h DNP treatment, HeLa ATP levels decreased ϳ85% compared with only 51% in fibroblasts (Fig. 5D) . The preservation of energy substrates in fibroblasts may be a result of different glycolytic capacity in these two cell types. After DNP exposure, lactate production (micromoles/ milligrams of protein/24 h) in fibroblasts increased from 11.5 Ϯ 0.9 to 16.5 Ϯ 1.3, whereas a similar treatment in HeLa cells resulted in a slight reduction of lactate production from 6.7 Ϯ 0.2 to 6.2 Ϯ 0.2. These differences in energetics seen with chemical uncoupling were reflected in a difference in cell survival. After 48 h of DNP exposure, ϳ87% of DNP-treated fibroblasts remained viable compared with only 36% HeLa cells (Fig. 5E) . Thus, the effects of protein or chemical uncoupling on mitochondrial energetics and viability appear cell type-specific.
To further understand the physiological significance of uncoupling proteins in cellular oncosis, we made use of the fact that uncoupling proteins are dimeric proteins and that a significant number of structure-function analyses have already been performed on the closely related UCP-1 (21) . In particular, a number of specific residues have been implicated in proton binding and transport. We reasoned that the analogous mutations in UCP-2 should result in a protein with reduced activity, and given the dimeric form of the protein, such mutations should act in a dominant interfering fashion. Given that basal uncoupling rates are in the range of 25% (22), we predicted that any putative dominant negative UCP-2 mutant should raise basal mitochondrial membrane potential. We tested a series of site-directed mutants of UCP-2 at amino acid positions D28N, R185G, and D212N, because the corresponding mutations in UCP-1 (position 28, 183, and 210) have been shown to alter nucleotide binding, proton transport, or pH sensing (21) . Following transfection with these mutant UCP-2 constructs, cells were assessed for CMXRos uptake. FACS analysis of UCP-2 mutants at position 27 and 185 revealed no appreciable change in resting membrane potential when compared with control-transfected cells. 2 In contrast, the cells that expressed UCP-2 D212N had a significant increase in the resting mitochondrial membrane potential (Fig. 6, A-C) . However, the uptake of the non-potentiometric dye Mitotracker Green was unaffected by UCP-2 D212N expression (Fig. 6D) . The UCP-2 dominant interfering mutant allowed us to further explore the physiological role of uncoupling in cell death. As such, we next subjected control-transfected or cells that expressed UCP-2 D212N to either a primarily apoptotic or oncotic stimulus. As seen in Fig. 7A , the expression of UCP-2 D212N did not significantly alter the response to staurosporine, a rapid inducer of apoptosis in HeLa cells. A similar lack of effect was noted with tumor necrosis factor and cycloheximide treatment (Fig. 7B) . In contrast, the expression of UCP-2 D212N afforded significant protection to cells exposed to the primarily oncotic stimuli of metabolic inhibition using sodium azide (Fig. 7C ) or chronic hypoxia (Fig. 7D) . Taken together, our results suggest that UCP-2 can regulate cellular energetics and specifically alters the response to oncotic stimuli.
DISCUSSION
Some degree of uncoupling exists in many if not all cells and tissues (23) , and evidence suggests that this uncoupling might be useful in limiting the chronic exposure to harmful reactive oxygen species generated in the mitochondria (24, 25) . Although clearly useful under normal conditions or under severe or chronic metabolic stress such as hypoxia or anoxia, the inefficiency inherent with uncoupling may provide a significant disadvantage in cellular survival. Accordingly, our data show that even modestly increased levels of UCP-2 protein reduces cell survival in certain cells. Consistent with this conclusion is the observation that mice with fatty livers and subsequent elevated levels of hepatic UCP-2 appear more susceptible to ischemia-reperfusion stress than control mice (26) . Similarly, recent studies using oxygen injection microcalorimetry have demonstrated that the level of uncoupled respirations is reduced when intracellular oxygen concentrations fall (27) . This finding suggests that uncoupling activity is physiologically regulated during hypoxic stress, and as we have demonstrated here, cells with reduced levels of uncoupling may have a survival advantage during prolonged ischemia.
UCP-1 that is overexpressed in yeast and mammalian cells retains its native fatty acid-dependent uncoupling and thermogenic activities, but it remains controversial despite their high degree of structural similarity whether or not the functions and regulation of UCP-2 and UCP-3 are identical to UCP-1 (28) . Recent evidence from UCP-2 knock-out animals supports the notion that UCP-2 functions in vivo as a regulator of mitochondrial coupling and membrane potential (29) . It has recently been proposed that sufficient overexpression of any inner membrane mitochondrial proteins may result in nonspecific uncoupling (30) . Although this may be true for massive overexpression in experimental models in yeast, we found that in contrast to UCP-2, ANT-2 overexpression in HeLa cells did not alter membrane potential or cell viability. Similarly, overexpression of the UCP-2 D212N mutant not only failed to reduce membrane potential but in fact raised membrane potential. These results strongly suggest that the effects we observed on mitochondrial membrane potential following wild type UCP-2 overexpression in HeLa cells resulted from the specific action of UCP-2 and not from mitochondrial protein overloading.
Considerable progress has been made in elucidating the molecular and biochemical events that regulate apoptosis. These studies have demonstrated that the mitochondria play a pivotal role in the coordination, initiation, and execution of apoptotic cell death. Despite its common misinterpretation as necrosis (4), it has long been recognized that oncosis represents a morphologically distinct mode of cell death, yet the molecular basis underlying oncosis has received little attention. Our results demonstrate that the expression of UCP-2 is sufficient to induce oncosis in certain transformed cells, whereas transient inhibition of UCP-2 can selectively protect these cells from oncotic but not apoptotic stress.
As such, these data suggest a central role for mitochondria in regulating oncotic cell death and add to the evidence that oncotic cell death may also be subjected to molecular regulation and may play a homeostatic role in the overall tissue response to acute metabolic stress. Finally, our results also raise the possibility that other gene products in addition to UCP-2 may be identified that will selectively modulate the cellular response to oncotic stimuli without affecting the overall cellular threshold to apoptosis. Such an analysis should provide a more detailed molecular basis to distinguish what until now has been a purely morphological distinction between these two contrasting forms of cell death. In addition, further studies of oncosis will provide a deeper understanding of this important biological process and provide the framework for new therapies directed at protecting tissues and organs from severe metabolic and ischemic insults.
